David Zaccardelli | Chief Executive Officer |
Mark Hahn | Chief Financial Officer |
Kathy Rickard | Chief Medical Officer |
Chris Martin | Senior Vice President-Commercial |
Suji Jeong | Jefferies |
Boobalan Pachaiyappan | H.C. Wainwright |
Tom Shrader | BTIG |
Welcome to Verona Pharma's, Third Quarter 2022 Financial Results and Operating Highlights Conference Call. At this time all participants are in a listen-only mode. Earlier this morning Verona Pharma issued a press release announcing its financial results for the three months ended September 30, 2022. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.
Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements.